Media Summary: Artificial intelligence is beginning to reshape oncology drug development, especially for companies that can use it not only to ... In a NASDAQ Breakthrough Economy interview, CEO Panna Sharma talks with host Jen Rogers about the evolution of AI in ... 90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and years of development time.
Lantern Pharma Ltrn 41 5m - Detailed Analysis & Overview
Artificial intelligence is beginning to reshape oncology drug development, especially for companies that can use it not only to ... In a NASDAQ Breakthrough Economy interview, CEO Panna Sharma talks with host Jen Rogers about the evolution of AI in ... 90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and years of development time. We were excited to host Tribe Public's Webinar Presentation and Q&A Event on Thursday, February 9 (8:00am PT / 11:00 am ET). Biotech investors and oncology researchers: 0:00 Intro 3:40 2024 Q2 Highlights 15:10 Financial Highlights 18:55 Harmonic Highlights 36:10 Starlight Therapeutics 37:10 ...
![[LTRN Webinar] Lantern Pharma Webinar Wednesdays - Childhood Cancer Awareness Month](https://i.ytimg.com/vi/sLJjhFuR-KU/mqdefault.jpg)
![[LTRN Webinar] Actuate Therapeutics x Lantern Pharma AI Collaboration](https://i.ytimg.com/vi/HwaxjU_PRzQ/mqdefault.jpg)
